Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.
- DOI
- 10.1111/bju.70443
- Published
- 2026 Sep 13
- Container
- BJU international
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/bju.70443,
title = {Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.},
author = {Marte JL and Hankin A and Williams M and Gulley JL and Karzai F and Bilusic M and Cordes L and Figg WD and Madan RA and Abel ML},
year = {2026},
journal = {BJU international},
doi = {10.1111/bju.70443},
url = {https://doi.org/10.1111/bju.70443}
}RIS
TY - JOUR TI - Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity. AU - Marte JL AU - Hankin A AU - Williams M AU - Gulley JL AU - Karzai F AU - Bilusic M AU - Cordes L AU - Figg WD AU - Madan RA AU - Abel ML PY - 2026 JO - BJU international DO - 10.1111/bju.70443 UR - https://doi.org/10.1111/bju.70443 ER -
APA
JL, M., A, H., M, W., JL, G., F, K., M, B., L, C., WD, F., RA, M., & ML, A. (2026). Intermittent enzalutamide in recurrent prostate cancer: testosterone kinetics and related toxicity.. BJU international. https://doi.org/10.1111/bju.70443
Source records
- pubmed · retrieved 2026-09-24T21:42:19.296Z